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ABSTRACT 
Background: Cell based transplantation methods are a pivotal part of the emerging 
field of regenerative medicine. These transplantation methods could possible produce 
curative treatments where, previously, expectations of such feats were low. Diseases for 
which treatments are evaluated are in such diverging physiological systems as e.g. the 
CNS with ischemic or traumatic injuries, the endocrine system with type I diabetes 
mellitus, or musculo-skeletal system with dystrophies, hematological system with 
leukemia and cardio-vascular system with ischemic heart disease among others. 
Transplantation methods for cells span from open surgical/percutaneous, over 
intravenous, to specific intra-arterial methods. The method for delivery of cells is in 
fact an important part of the translation of cell based therapies to clinical practice. With 
that said, the use of endovascular techniques opens attractive routes of transplantation 
that needs to be thoroughly studied in order to achieve maximum efficacy. 
 
Methods: We have utilized a model of traumatic brain injury in the rat where cell 
transplantations have been performed by selective intra-arterial methods and compared 
to intravenous administration. Analysis of engraftment has been performed by 
immunohistochemistry and cell characterization has been performed by microarray and 
RT-qPCR. Further, we have developed the Extroducer catheter system, a “nano”-
catheter aimed for trans-vessel wall technique passage, in simulator, ex vivo, in vivo in 
rat and with full clinical integration in rabbit and swine. Long term follow-up studies 
have been performed both in rat (14 days) and rabbit (5, 30 and 80 days). 
 
Results and Conclusions: We first show that selective intra-arterial methods increase 
engraftment levels up to fifteen-folds higher compared to intravenous controls. 
However, not all cell systems are found to be optimal for intra-luminal transplantation 
methods. Some of the factors limiting engraftment were thus explored within the cell 
systems themselves. These findings indicated that lack of engraftment might be 
dependent on integrin expression and endothelial interactions. For cells that lack the 
capacity of diapedesis and especially for more specific niche cell systems, such as 
insulin producing cells in the pancreas, the Extroducer can create direct parenchymal 
access via the endovascular route. Thus, the Extroducer system, developed within this 
thesis, offers a working channel between the proximal end of an endovascular catheter 
and the parenchyma of any organ of the body. Development and testing verified 
integration with clinical routine catheters. No long term adverse events were observed 
in the rat or the rabbit following the trans-vessel wall passage. In conclusion, 
endovascular intervention can provide a number of conceptually different methods for 
cell transplantation. 
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INTRODUCTION 
Results from cell transplantation research have received interest and attention both 
from a clinical, a scientific and a public point of view. This thesis discusses new 
transplantation methods for different cell systems. In the introduction, different cell 
based therapies are presented followed by an overview of pathological conditions 
wherein several cell based strategies are implemented. Thereafter the delivery of cells 
in broad terms, and then specifically by endovascular technique compared to surgical 
technique, is presented. Ending the introduction is a general description of the active 
process of diapedesis as it is understood for immunological cells, followed by the broad 
aims of the thesis and then the succinct aims of the thesis in bullet points. The thesis 
includes numerous and quite divergent methods and we provide a short summary of the 
methods and methodological considerations in this text. More detailed descriptions of 
the methods used are found in respective paper. Finally, results and a general 
discussion followed by conclusions from the work presented are provided. The main 
results are also all presented in the articles comprising this thesis. 
Cell based therapies 
Cell based strategies are sought after as a way of repairing or to facilitate self renewal 
in pathological organ systems that have little or no regenerative capacity of its own. 
The plethora of different diseases in organ systems that might have a regenerative 
capacity, but is limited through physiological processes, is almost boundless (Bajada et 
al. 2008). Cell based therapies have been successfully used in the clinical practice for 
distinct pathological conditions during a relative long period of modern medicine. One 
of the broadest success stories are the transplantation of cells to patients suffering from 
hematological diseases (Buckner et al. 1974; Thomas et al. 1975; Thomas et al. 1975; 
Slavin et al. 1998). Hematological stem cell transplantation has also been expanded to 
comprise autologous transplantations following chemotherapy of solid tumor forms 
(Childs et al. 2000). Following the isolation of stem cell lines from human blastocysts 
(Thomson et al. 1998) and other adult sources such as the central nervous system 
(CNS) (Johansson et al. 1999), bone marrow (Bruder et al. 1997), multi-lineage 
mesenchymal (Pittenger et al. 1999), adipose tissue (Zuk et al. 2001) among others, 
new cell based approaches to disease treatment can be envisioned. The potential for in 
vivo expansion of these cells followed by transplantation, re-implantation and/or tissue 
engineering becomes possible (Vacanti et al. 1999). These findings open up 
possibilities for strategies aimed at ameliorating disease burden, or in the long run, 
obtaining curative goals through cell therapies in a clinical setting. Proposed treatments 
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can broadly be divided into stimulation of an endogenous population or transplantation 
of cells (Lindvall et al. 2006), be them homologous, from a donor or across the xeno-
barrier. The wider implications of the prospect of cell based treatments are summarized 
in a review article where the coining of the effort and/or subject of Regenerative 
Medicine is presented (Daar et al. 2007). 
The CNS has attracted attention since the potential of restored function could be very 
valuable for patients. Particularly since pathological conditions in the CNS can be 
severely disabling. Cell based therapies are in clinical trials in e.g. Parkinsons Disease 
(Freed et al. 2001; Gordon et al. 2004), ischemic stroke (Kondziolka et al. 2000; Bang 
et al. 2005) and spinal cord lesions (Sykova et al. 2006). Outside the CNS, other 
clinical trials with cell based therapies aimed at e.g. muscle dystrophy (Gussoni et al. 
1997; Miller et al. 1997), ischemic heart disease (Stamm et al. 2003), graft versus host 
disease (Le Blanc et al. 2004; Ringden et al. 2006) and type I diabetes mellitus (Scharp 
et al. 1991; Shapiro et al. 2000; Korsgren et al. 2008) have yielded promising results. 
So far, many of the cell therapies are still in trials since both safety and effects must be 
thoroughly evaluated. 
In many areas of pre-clinical, and to some extent clinical research, cell based 
therapies deliver positive results. However, as with the definition of stem 
cells/progenitor cells (Potten et al. 1990) the field of cell based therapies are a very 
heterogeneous one (Bajada et al. 2008). One feasible way of applying taxonomy to this 
field is by discussing different basic components in the treated diseases. The first 
example would be in pathological conditions with a definable population of cells being 
defect. Examples of diseases with certain cell types being depleted are Morbus 
Parkinson - dopamine producing cells, (Lindvall et al.), muscle dystrophy -satellite 
cells of the muscles (Gussoni et al. 1997) and type I diabetes - insulin producing cells 
(White et al. 2001). Such specialized cells might be easier to replace than the second 
general idea of cell transplantation wherein attempts of transplantation is aimed at more 
intricately functioning physiological systems. The complexity increases steeply when 
transplanted cells must differentiate into subpopulations of cell and/or interact within 
networks (e.g. the CNS). An example of that would be the transplantation of neural 
progenitor cells with the aim of full neural integration (Nikolic et al. 2009). A third 
strategy is to exert effects on existing cells/organs through transplantation but without 
functional integration. This strategy might explain some of the results from studies 
aimed at integration of cells, but without engraftment in the target organ, albeit with 
positive functional results observed (Borlongan et al. 2004). One explanation for that 
phenomenon is that in more complex situations, such as following CNS insults, some 
of the reported beneficial effects might be associated with immune modulation or local 
secretion of growth factors, thereby rescuing cells from apoptosis. Examples of 
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immune modulation could be Fas-ligand expressing cells (Ghio et al. 1999; Nagata 
1999; Lee et al. 2008) whereas secretion of growth factors could be exemplified by an 
over-expression of IGF-1 from transplanted mesenchymal cells (Haider et al. 2008). 
Modulation of the immunological response by cell transplantation has also been shown 
to favorably treat graft versus host reactions in clinical practice (Le Blanc et al. 2004; 
Ringden et al. 2006). The concept of transplantation of cells serving as self renewing, 
local, biologically active, pharmacological factories are attractive for many parts of 
regenerative medicine (Amar et al. 2003). Local, self-sustaining, treatments that are 
only affecting niche parts of organs have many benefits that might include, but are not 
limited to, higher local concentration, less risk of adverse events and customization to 
different pathological conditions. 
Delivery of cells 
For cell transplantation, different percutaneous techniques assisted by modern 
imaging are viable through minimal invasive methods (Bale et al. 2007) and most parts 
and locales of the human body can be reached with that approach. On the other hand, 
for organs with less accessible anatomical location, parenchymal access can be 
associated with significant surgical risks (Villiger et al. 2005; Ben-Haim et al. 2009). In 
situations where engraftment rate after intraluminal cell administration is low and when 
a high anatomical specificity is required, such as the scenario when replacing a distinct 
cell type, direct puncture of the parenchyma might be preferable. For CNS applications 
this can be done with stereotactic needle puncture or in a combination with open 
surgery (Hagell et al. 2002; Wennersten et al. 2004). 
Direct parenchymal access can also be achieved by endovascular technique. An 
example of this is a system that adds a possibility to, via large veins, administrate cells 
to the heart parenchyma (Thompson et al. 2003). The design of that system, requiring a 
large diameter catheter and without a closure device for the penetration site makes it 
usable only in large vessels on the venous side, more specifically, in the coronary sinus 
of the heart (Thompson et al. 2003; Siminiak et al. 2005). Other organs that might be 
difficult to reach, such as the CNS and the pancreas, are not reachable by the 
transvenous technique due to the design of that system requiring a large catheter 
diameter. Furthermore, venous navigation to most parts of the CNS and the pancreas, 
and to certain parts of the heart, is very difficult due to more unpredictable venous 
anatomy and venous valves. 
Insulin producing cells are today transplanted by a hybrid method with percutaneous 
access to the portal vein and then intra-luminal cell release in the bloodstream. The 
concept of the intra portal transplantation is considered superior to open surgical 
techniques, due to the un-acceptable risk of adverse events (Kandaswamy et al. 1999; 
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Humar et al. 2000). The risk-analysis naturally differs substantially for different 
surgical procedures and transplantations, both with respect to organs and cells. Risks 
with portal vein transplantation include portal vein thrombosis, hemorrhages, and 
transient increase of transaminase values (Shapiro et al. 1995; Ryan et al. 2001). A 
continuous work of reaching a balance between the risk of bleeding after the procedure 
and portal vein thrombosis is of utmost importance for portal vein transplantations and 
results are improving steadily in clinical trials. Further adding to the risk side of the 
comparison is the need for immunosuppressant treatment after transplantation. The 
potential benefit of the procedure must also, as in the case with diabetes and insulin 
producing cells, be compared to the standard treatment of insulin injection and or 
pumps. Inclusion criteria for portal vein transplantation of insulin producing cells are 
thus already subject to immunosuppressive therapy for other previous transplantations, 
patients with unstable glycemia, unawareness hypoglycemia, or progressive chronic 
complications despite intensive insulin treatment (Bertuzzi et al. 2006). Simultaneously 
it has been suggested that it would be of great benefit if insulin producing cells could be 
transplanted directly to the parenchyma of the pancreas. Advantages with pancreas as 
the target locale are e.g. the possibility of mimicking the physiological release of 
insulin and due to a more hospital micro-environment for the insulin producing cells; 
the pancreas has a higher oxygen tension compared to the liver (Merani et al. 2008). 
Many different strategies of cell based therapies are being evaluated in both pre-
clinical and clinical trials. As previously stated, this thesis pertains to the delivery 
methods of cells to the different organs. One of the larger obstacles that have been 
observed is that the lung acts as a kind of clearance filter for the intravenous cell 
infusion, resulting in pulmonary trapping (Barbash et al. 2003; Fischer et al. 2009). An 
intra-arterial selective approach would possibly result in higher transplantation 
efficiency in certain conditions. The versatility of cell suspensions must not be 
underestimated and limit the way of thinking when considering treatments with cell 
based approaches (Nikolic et al. 2009). The cell suspensions can easily be handled and 
administrated through tubing and catheters, thus providing the possibility to by-pass the 
lung and selectively reach designated target vessels/parenchyma with a first passage 
effect. Those possibilities of cell handling forms the basis for this thesis on catheter 
based strategies for cell transplantation. 
Endovascular treatments are continuously providing a third option to open surgical or 
percutaneous approaches. From the establishment of the Seldinger technique (Seldinger 
1953) and the first use of digital subtraction angiography (DSA) (Meaney et al. 1980) 
to the modern interventional lab with 3D road maps (Soderman et al. 2005) and CT like 
capacities of the C-arm (Soderman et al. 2008) the path has been long but rapidly 
progressing. The driving force up until today, that has made the leap ward style of 
Lundberg, 2011 
 
  5 
improvements possible, is both rapid developments in computational power and 
material sciences. The arteries and veins can today be regarded as “internal routes” for 
navigation, diagnosis and intervention. The shift from open surgical options is for 
example illustrated by the patients that used to undergo thoracotomy and that now are 
being referred for percutaneous coronary intervention or the established coiling of 
intracranial aneurysms instead of open neurosurgical operation. 
Scaling from bench to bedside 
As this thesis hopes to illustrate; the rapid development of endovascular technique has 
implications on cell transplantation methods as well. To illustrate these implications as 
opposed to organ transplantation, one can visualize a liver transplantation. The wound 
in the abdominal wall must at least be big enough for the liver to go into the patient. 
This severely limits the possibility of minimal invasive transplantation of organs. On 
the other hand, the versatility of cell suspensions could make intra-luminal techniques 
the natural way of access. In experimental trials, open surgical options are used in e.g. 
rodent models for transplantation with positive results. This presents a limitation of 
scalability for clinical translation. For instance, when evaluating pre clinical CNS 
transplantation schemes in rodents one or two burr holes are established and cells are 
transplanted. One or two injections in the rat brain covers a relatively large volume but 
when scaling that to the human brain following e.g. a middle cerebral artery ischemic 
event, a large number of percutaneous trajectories would be required to cover a human 
brain volume corresponding to the experimental situation. The migratory capacity for 
transplanted mesenchymal cells after stereo-tactical transplantation has been shown to 
be around two millimeter over 14 days (Chen et al. 2001). Furthermore, the mechanical 
neuronal injury and the risk for intracerebral hemorrhage would increase with each 
injection trajectory. In brain stimulation procedures, the literature is somewhat 
divergent; the risk for hemorrhage could be as high as 5% per injection (Ben-Haim et 
al. 2009). The easier clinical scalability of endovascular access comes in the terms of 
cells delivered to a larger volume of tissue by taking advantage of the already existing 
vascular system. If an ischemic stroke occurs due to a vessel occlusion at some point, it 
would be very tempting to intraluminally disperse cells from the same point via the 
vascular system in order to reach the affected parenchyma. A normal cell dose for a 
human adult would probably at least be hundredfold higher than in the rodent and 
needs to spread out over a vastly larger volume thus requiring many injection 
trajectories. The average human brain weight is quoted at around 1400 grams as 
opposed to the adult rat at 2 grams to give some sense to the scale proportions. 
Endovascular intervention is not without risks either, exemplified by the risk of 
adverse events reported at 0 to 4.0%, commonly reported at 0.5%, in different cerebral 
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interventions (Raymond et al. 1997; Cognard et al. 1998; Ng et al. 2002; Murayama et 
al. 2003; Gonzalez et al. 2004; Cronqvist et al. 2005). Added to the risk of the 
procedure per se is the risk of cell transplantations. The risk of intra-arterial 
transplantation has already been documented in humans for up to 24 months without 
severe complications, albeit in a small material (Sykova et al. 2006). Other pre-clinical 
studies with intra-arterial coronary injections performed in healthy dogs revealed 
micro-infarction of the heart parenchyma (Vulliet et al. 2004) whereas that has not been 
observed in clinical studies (Stamm et al. 2003). Factors that might be limiting are the 
size of the cells injected versus the size of the capillary system, the proportion of shunts 
in the microcirculation, the stickyness of the cells and the amount of cells 
administrated. Many of the cells have a much larger diameter (10 up to 70 µm) as 
opposed to the capillaries 5 to 8 µm (Chien et al. 1975). The shunting zones in the 
microcirculation could potentially lead also large cells to the post-capillary venules 
where diapedesis usually occurs (Tuma 2008). The main reason for leukocyte 
adhesion/diapedesis through venules is the usually restricted expression of adhesion 
molecules on venular but not arteriolar or capillary endothelium (Tuma 2008). In 
intravital microscopy studies, adipose mesenchymal cells have been shown to act as 
embolic material (Furlani et al. 2009). This risk could be speculated on to be lower than 
the comparable trauma of the surgical methods although a final risk assessment requires 
a randomized clinical trial. 
Leaving the bloodstream - diapedesis 
One limiting factor to specific intra-arterial and intravenous transplantations is that an 
intra-parenchymal approach yields a higher efficacy. It has been shown that when 
performing transplantations to a rodent stroke model and comparing intravenous, intra-
ventricular and intra-striatal injections, the highest efficacy in sheer number of cells 
were obtained with the intra-striatal route (Jin et al. 2005). Further limiting the selective 
intra-luminal approach is the speculation that some cell systems, such as insulin 
producing cells, appear incapable of leaving the bloodstream (Hirshberg et al. 2002). 
In all implementations aimed at intra-luminal administration (intra-luminal 
encompassing both intravenous and selective intra-arterial administration) the ability of 
the cells to leave the bloodstream, or perform diapedesis (Fulton et al. 1957) is 
fundamental. The diapedesis function has previously been studied predominantly in 
immunological cells (Fulton 1957), it is in fact the active process whereby cells leave 
the bloodstream. The diapedesis of immunologically active cells has been thoroughly 
studied since the discovery of the significant multistep, ordered, cross-talk procedure of 
leukocyte-endothelial cell interaction both in vitro and in vivo (Butcher 1991; Springer 
1994). 
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The barricades limiting the cells from haphazardly leaving the bloodstream are many. 
All blood vessels contain an endothelium and several organized barriers. In the CNS for 
instance, tight junctions are located between endothelial cells, predominantly to permit 
the conservation of the water fraction of the blood stream. The liquid pressure gradient 
composed of the blood pressure can be broken down to one force directed with the axis 
of the laminar flow of blood and one force aimed perpendicular to the flow on to the 
wall (Glagov et al. 1992; Fay 1994), thereby providing an evolutionary rationale for 
sealing the blood stream tightly. Situated underneath the endothelial cells and forming 
their structural base sits the basal layer; a specific protein structure composed of extra 
cellular matrix (ECM) proteins abundant with expression of elastin, laminin and 
collagen type I, III and IV (Mayne 1986). Collagen and elastin are the major structural 
components of blood vessels of all sizes throughout the mammal body. The cross-
banded fibrils, visualized by electron microscopy in the tunica media and tunica 
adventitia formed by type I and type III collagen provide the tensile strength and 
comprise probably 80 to 90% of the total collagen present. The other major structural 
protein component in elastic arteries is elastin; the protein that provides the elastic 
component of the blood vessels (Mayne 1986). Around most capillaries, pericytes also 
further seal the blood stream. These cells are less abundant in the post capillary venules 
where most of the diapedesis occurs. As a general note the post capillary venules are 
the most “leaky” part of the vascular tree. It should be noted that blood vessels are not 
merely the plumbing in the mammal body, it is in all respects a vividly living part of 
the organism reorganized as a response to stress and demand (Gibbons et al. 1994) and 
among other things has a self-generating electro potential towards the bloodstream that 
is important for the clotting cascade (Danon et al. 1976). 
As previously mentioned, in a diverging literature it has been speculated that some 
cells totally lack the function of exiting the blood stream, thereby limiting intra-luminal 
based techniques. Even though insulin producing cells appears incapable of leaving the 
bloodstream, they are still transplanted through the portal vein (Hirshberg et al. 2002). 
The mechanism of action is believed to be microembolization of the cells to the liver 
parenchyma in the low pressure system that the portal vein constitutes (Lehmann et al. 
2007). It has been speculated that arterial blood from the hepatic artery pushes pack 
into the portal vein during the mixing of the two flows which would stop the cells and 
create advantageous conditions for engraftment. The cells found functioning in the 
livers of transplanted patients are, however, situated as plaques in the hepatic artery tree 
thus adding yet another hurdle to the understanding of portal vein transplantation. The 
hypothesis is that the cells cannot perform diapedesis but are instead primarily forming 
a mural thrombus after, with low probability, being displaced against the blood flow 
into the arterial tree and then encapsulated by endothelial cells. The plaque formation 
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can thereby provide capillary ingrowth, an absolute requirement for endocrine function 
(Korsgren et al. 2008). Such a hypothesis would also shed further light on the low 
efficacy of portal transplantations methods. Nevertheless, the portal vein approach to 
transplantation is today the golden standard since the existing open surgical options of 
total pancreatic transplantation carries a mortality risk of 10% during the first year of 
follow-up (Kandaswamy et al. 1999; Humar et al. 2000). 
The process of diapedesis is basically divided into tethering, rolling and stopping of 
leukocytes prior to diapedesis into inflamed tissue. It is thought of as a multistep 
procedure involving complex crosstalk between cells in the bloodstream and the 
endothelial cells. On the endothelial side intra-cellular adhesion molecule -1 (ICAM-1) 
(Dustin et al. 1986; Rothlein et al. 1986), vascular cell adhesion molecule -1 (VCAM-
1) (Elices et al. 1990; Pulido et al. 1991) and junctional adhesion molecule –A (JAM-
A) have all been implicated to play crucial roles. Interestingly, all of these receptors are 
part of the Ig-super family. Leukocytes capacity for homing and diapedesis is pivotal 
for the development of the inflammatory response to injury and starts as a tightly 
controlled up-regulation of endothelial E- and P-selectins that stimulate the leukocytes 
(Vestweber et al. 1999). These leukocytes then respond by activation of G protein-
coupled receptors that increase the affinity for endothelial VCAM-1 and ICAM-1 
(Muller 2003). Interaction with VCAM-1 is maintained through the heterodimer CD29 
and CD49d forming the cell surface antigen Very Late Antigen – 4 (VLA-4) (Elices et 
al. 1990) and the CD11aCD18 heterodimer interacting with ICAM-1 (Meerschaert et 
al. 1995). VCAM-1 and ICAM-1 have previously been shown to be up-regulated on 
the endothelium as a response to inflammation (Dustin et al. 1986; Pulido et al. 1991). 
This interaction starts the diapedesis itself wherein the leukocytes “crawl” through, 
either a para-cellular or a trans-cellular pathway interacting with both PECAM-1 and/or 
CD99 or members of the JAM family of proteins (Petri et al. 2006). Thus significant 
crosstalk is needed to initiate and execute the active process of diapedesis. 
VCAM-1 is also implicated both as a model of treatment for immunological 
modulation of the inflammatory responses following CNS insults and as surface 
antigen for cell treatment of CNS insults. In one study, fluorescence activated cell 
sorting (FACS) was performed for the expression of CD49d and identifying it as one of 
the important factors for directing diapedesis (Guzman et al. 2008). This finding has 
received a lot of interest from different fields, among other it has been shown that 
VCAM-1 expression has a critical role in transplantation of cells in dystrophic muscle 
(Gavina et al. 2006). Another utilization of VCAM-1 is the selective blocking by the 
monoclonal antibody drug Natalizumab used in multiple sclerosis, thereby inhibiting 
diapedesis for immunologically active cells (Stuve et al. 2008). VCAM-1 blockade has 
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also been tested for neuroprotective effects following ischemic events in pre-clinical 
trials with disappointing results (Justicia et al. 2006). 
Broad aims of the thesis 
This thesis over-arching aims are all connected to different optimization methods for 
cell based transplantational techniques. The first hypothesis tested in I and II are that a 
selective intra-arterial approach has benefits over intravenous administration. When 
performing study II and realizing that all cells where not optimal for intra-luminal 
approaches, a more detailed analysis of cells were included in that study broadening the 
thesis to include analysis of the molecules involved in the active diapedesis process. 
The aims of part of this thesis are therefore to compare different cell system in 
engraftment levels to the CNS and to further illuminate the active process of the cells 
that leave the bloodstream in order to achieve a reasonable engraftment. During the 
development of the specific intra-arterial approach utilized in I and II, the interesting 
finding that all cell systems were not optimal for intra-luminal approaches, a problem 
shared by other cells such as insulin producing cells, made it clear that yet another 
approach was desirable. Hence, in an attempt for providing a third method for minimal 
invasive transplantations, the development of the trans-vessel wall technique was 
initiated as described in III. This device pertains to cells that lack the possibility to 
leave the bloodstream and subsequent aim of that part of the thesis is to test the 
possibility of using the system to achieve parenchymal access and then test the possible 
long-term effects of such an intervention as performed in IV. It was originally intended 
for CNS applications, however, the aims where then broadened to “hard-to-reach” 
organs in the entire body. A caveat at this point is that the purpose of the studies 
compiled in this thesis is, in part, not regenerative medicine since the primary outcome 
of none of the studies actually measures regeneration. Nevertheless, an integrated part 
of translation of cell based therapies to the clinical practices is in our opinion the 
method of delivery of cells to the recipient. Therefore the use of endovascular means 
needs to be thoroughly studied in order to facilitate the maximum efficacy of 
transplantation methods. Characterization of not just regenerative capacity of the cells 
themselves seems important but also the capacity of the cells to reach the proper site of 
engraftment where any transplantation effect can be maximized.  
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AIMS OF THE THESIS 
 
i. To investigate if it is possible to transplant cells to the CNS by selective 
endovascular technique. 
 
ii. To compare selective intra-arterial with intravenous methods of cell 
delivery to the CNS. 
 
iii. To test different cell systems in the same transplantation setting and 
subsequently investigate if any differences arise with engraftment. 
 
iv. To investigate if it is possible to use trans-vessel wall technique methods 
for cell transplantation and substance administration with standard 
clinical catheters and angiographical equipment without hemorrhagic or 
thrombo-embolic complications. 
 
v. To study the long term effects of implanted device through the vessel 
wall. 
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METHODOLOGICAL CONSIDERATIONS 
This thesis comprises a significant amount of methodology development. To avoid 
repetition and lengthy descriptions, all steps are not included in this text. A detailed 
description of materials and methods are provided in the original articles and 
manuscripts. Herein short descriptions of commonly used methods and somewhat 
lengthier descriptions about non-standard methods are outlined. Further, advantages, 
disadvantages and methodological considerations behind some of the experiments are 
presented. 
Cell preparation (Paper I and II) 
All human cell isolations were approved separately by the Southern Regional Ethics 
Committee of Stockholm. All animal handling and protocols for rat cell isolation were 
approved by the Northern Regional Ethics Committee of Stockholm. 
All cell systems transplanted were isolated/generated in the laboratories of Prof. 
Katarina Le Blanc (human mesenchymal stem cells, hMSC), Associate Prof. Erik 
Sundström (human neural progenitor cells, hNPC) and Associate Prof. Ola Hermanson 
(rat neural progenitor cells, rNPC) through cooperation between the research groups 
that participated in the transplantation studies. 
hMSC were isolated from bone marrow taken from the iliac crest of healthy 
volunteers, as previously described (Grinnemo et al. 2006). hNPC were derived from 
the subcortical forebrain of human first trimester embryos as previously described 
(Joseph et al. 2009). Generation of rNPCs was carried out as previously described 
(Akesson et al. 2007). Prior to transplantation, the cells were mechanically dissociated 
and prepared to a final concentration of 50000 cells per µl. Different cell concentrations 
were also tested ranging between 10000 cells per µl to 100000 cells per µl (un-
published results). 
Animal management (Paper I through IV) 
A total number of 463 animals have been utilized in the laboratory work, not counting 
animals used for cell isolation. Of these animals, 434 were rats, 28 were rabbits and 2 
were swine. The vast majority of the animals have undergone multiple operations. In 
close collaboration with the animal handling facilities, the utmost care has been taken 
to reduce the suffering and provide stimulation to each and every animal. The majority 
of rats have not been included in published papers due to preliminary studies 
establishing models and negative results. All animal studies were conducted according 
to Karolinska Institutet guidelines of animal experiments on small rodents and rabbits 
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or the guidelines of swine handling. All studies were approved by the regional ethics 
committee for animal research in Stockholm, Sweden. Reduction of numbers of 
animals, replacement by simulations and refinement in experiments has been 
thoroughly considered during planning and execution of all studies. 
It is the author’s firm belief that in order to test the hypotheses of the studies 
performed for this thesis, the use of live animals is a necessity. The possible benefits of 
the studies performed, in the mind of the author, justifies the studies and the subsequent 
designs of the same. The author deployed reasoning from the utilitarian school for this 
position albeit reaching different conclusions than the ones of Peter Singer (Singer 
1976). 
Small Animal TBI and Transplantation procedures (Paper I and II) 
The TBI model was chosen since we, within the group, had previous experience with 
it (Holmin et al. 1997). The surgery can be performed quickly and gives rise to minimal 
behavior alterations thus lowering the detection threshold for ischemic adverse events. 
The endovascular route for cell transplantation was modified from a model for 
ischemic stroke; the middle cerebral artery occlusion model (MCAO) (Longa et al. 
1989). A separate model was developed and evaluated for MCAO followed by repeated 
surgery for transplantation (un-published results).  
One day following TBI, the animals were re-anesthetized and neck explorations were 
performed. Transplantations immediately after the TBI during the same anesthesia were 
also performed (un-published results). The transplantation procedure for intra-arterial 
administration included ligation of the ipsilateral external carotid artery. Thereafter, via 
the stump of the external carotid artery, cannulation of the internal carotid artery was 
performed with a nitinol alloy catheter (Nitinol superelastic tube with outer diameter 
0.193 mm ± 0.0127 mm, inner diameter 0.104 ± 0.0127 mm and length 300 mm (Tube 
NiTi SE 508, ground surface, Euroflex GmbH, Germany) connected to a microsyringe. 
After securing access to the vascular system, the nitinol-catheter was advanced in the 
internal carotid artery, passing the origin of the pterygopalatine artery towards the skull 
base. The use of the Nitinol tubing was chosen to mimic clinically available micro 
catheters and was the smallest possible fabrication of tubing with pushability at that 
time. The use of polyethylene tubing was also considered but that approach was never 
used since, for a more selective intra-arterial approach, the origin of the 
pterygogopalatine artery must be passed. Polyethylene is less rigid and thus less 
maneuverable than nitinol. Otherwise half of the cell suspension would be administered 
to the masseter muscles. 
Cell suspensions were then infused during two minutes. Blood flow in both the 
common carotid and internal carotid artery was preserved during the entire 
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transplantation procedure and only the external carotid artery remained ligated after 
surgery. For intra-venous transplantation, the nitinol catheter was inserted into the 
ipsilateral internal jugular vein via a neck incision and advanced through the superior 
thoracic aperture past the subclavian vein. The neck approach for intravenous 
administration was chosen to mimic the surgical trauma of the intra-arterial 
administration. Two hours post-operatively, animals were scored according to the 
Bederson scale for stroke classification (Bederson et al. 1986). The scoring was 
performed to provide clinical evaluation of a possible adverse ischemic event following 
the intra-arterial transplantation. 
Computer simulations and endovascular simulator (Paper III) 
Design simulations of the Extroducer were performed in COMSOL Multiphysics 
software (Comsol AB, Sweden). Designs were then tested in a system, scaffolded by 
iron tubing (ID 250 µm), on rat aorta ex vivo, cut longitudinally and hanging in free air 
between two connecting points on a cork plate. The cork plate was connected to a 
loading cell 1004-300 (AB Svenska våg, Sweden) which in turn was connected to a 
weight instrument LD5208 (AB Svenska våg, Sweden) giving real time output to a 
computer recording the force applied in the perpendicular direction of the inside of the 
vessel. Hereby forces could be measured for vascular penetration with the grinded 
nitinol tip and different depth limiting collars. Ratio calculations could be performed 
between penetration by the distal portion and different depth limiting designs. 
Important information could be gained from these experiments and further, the use of 
animals could be minimized. The ex vivo setup also provided a more controlled 
environment compared to in vivo to be able to utilize a large number of repetitions in 
trials with different prototype designs. 
An ex vivo simulation environment of the human vascular tree was constructed to test 
1700 mm long superelastic nitinol alloy tubes, with diameters as described under 
prototype manufacturing. A simulator of the human femoral artery, iliac artery, aorta, 
coeliac truncus and hepatic artery was constructed by connecting plastic tubing of 
decreasing size and mounting them on a plate. The distal end corresponding to the 
hepatic artery was then introduced in rat carcasses through the distal end of the 
abdominal aorta for ex vivo testing. Standard 6 F introducer, guiding catheter; Envoy 
(Cordis, USA) and micro-catheter; Prowler Plus (Cordis, USA) were used to navigate 
within the simulator. The nitinol tubes were deployed inside the standard clinical guide- 
and micro-catheter systems. Herein we tested the maneuverability of the system and if 
enough driving pressure could be applied to penetrate vessel walls. 
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Extroducer prototype manufacturing (Paper III, IV and un-published data) 
Several designs were tested but the only design tested in vivo was constructed in a 
similar fashion throughout all the papers. Briefly, we started with sharpening a tip from 
a super-elastic nitinol tube 1700 mm long with outer diameter 0.193 mm ± 0.0127 mm, 
inner diameter 0.104 ± 0.0127 mm (Tube NiTi SE 508, ground surface, Euroflex 
GmbH, Germany) in a faceted manner and connected the tube to a 25 µl micro syringe. 
A depth limiting collar was constructed by copper and cyanoacrylate glue and then 
formed into shape giving an added radius of 35 to 40 µm compared to the rest of the  
prototype. For construction of detachment zones, we applied a 3 µm thick parylene 
layer through gas polymerization in vacuum (ParaTech Coating AB, Sweden). Directly 
proximal to the depth limiting collar, a small insulation defect was cut through the 
parylene. We achieved electrolysis detachment of prototypes by applying 8 (rabbit) to 
10 V (swine) tension through a cathode needle placed in the hind limb and applying the 
other end to the prototype, making it the anode. This resulted in a circumferential 
dissolution of the catheter where the cut in the parylene was made. The distal 
penetration end was then separated from the proximal access portion of the nitinol tube 
thereby leaving the detached distal penetration end through the vascular wall. The distal 
penetrating tip thus provides the exit strategy for the intervention. 
The construction of the depth limiting collar was, in its entire construction and final 
result developed within the group. The largest problems in engineering in such a small 
scale are the magnitude of forces that are included in “visualization” of how it “should” 
work in relation to standard endovascular interventional procedures; here simulations 
were also helpful. The hollow detachment zone was also developed within the group, 
based on the electrolysis detachment  of the initial Guglielmi detachable coils 
(Guglielmi et al. 1991). 
Small Animal trans-vessel wall testing (Paper III) 
In the rat we tested a 300 mm long nitinol prototype that was introduced through the 
rat tail artery within a plastic PTFE-190 Sub-Lite wall tubing (SUBL) with outer 
diameter of 482± 0.025 µm and inner diameter of 330± 25 µm (AgnTho’s, Sweden). 
The plastic tubing was used to minimize damage to the vascular tree by the sharp 
penetrating tip. 
A new method for endovascular arterial access was developed with introduction of 
catheters via the medial tail artery. A small longitudinal incision was cut on the ventral 
part of the tail through the skin and the fascia overlying the artery. A ligature was used 
to secure the PTFE-190 tube containing the nitinol tube and then the catheter system 
was blindly navigated up through the aorta. Two significant advantages can be 
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achieved with tail artery access in comparison with the standard access via the femoral 
artery; the possibility to perform repeated interventions and the added possibility to use 
a more rigid system that would otherwise be difficult to navigate proximal to the aortic 
bifurcation. 
For observation and usage of the Extroducer prototypes, open surgical preparation of 
either the common carotid artery via a small mid-line incision medially on the neck, or 
the subclavian artery via an axillary exploration, were performed. To maximize surgical 
access and navigational success-rates, both the major and the minor pectoral muscles 
were cut. 
For all prototypes, tests to exclude vasospasm as a potential hemostatic cause were 
performed by soaking the perforated vessel with papaverin (Recip AB, Sweden) and 
observing it for 90 minutes. Mechanical manipulation and cannulation through the 
lumen of the detached Extroducer was also performed to stress-test the system for a 
possible hemorrhage.  
Rabbit endovascular intervention (Paper III and IV) 
Several different procedures were performed on rabbits. Trans-vessel wall technique 
Extroducer perforations were initially performed with fluoroscopical, angiographical 
and simultaneous open microsurgical monitoring. Thereafter, perforations were 
performed with fluoroscopical and angiographical monitoring only, followed by 
methylene blue- and contrast agent injection through the nitinol tube. During the later 
phase of testing, the procedures were finished by detaching the distal Extroducer 
portion by electrolysis and removing the proximal catheter system. 
All large animal angiography and surgery was performed with a Philips XD20 
angiographical equipment (Philips medical system, Netherlands). Without the 
resolution of the used system or a similar system, the navigation and subsequent testing 
of the Extroducer would not have been possible. Nitinol in these small dimensions is 
fairly hard to visualize but the addition of radiological markers at this stage, e.g. 
tungsten would have even further complicated the prototype manufacturing process. 
In planning the large animal trials all sorts of custom, or by hand manufactured 
materials for facilitating the endovascular intervention with the Extroducer prototype, 
were avoided to simulate the potential clinical application of the system and  the 
integration of the developed system with clinical standard material. The femoral artery 
of the anesthetized rabbit was exposed surgically and a 5 French Introducer was 
inserted in the artery (Terumo, USA). The artery is too small for a percutaneous 
approach since it is almost impossible to palpate through the skin. Under fluoroscopic 
and angiographic control, a 5 French Envoy guiding catheter (Cordis Corporation, 
USA) or a 4 French Vertebral guiding catheter (Terumo, USA) was navigated to 
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different parts of the vasculature of the rabbit. A Prowler Plus microcatheter (Cordis 
Corporation, USA) or Renegade high-flow micro-catheter (Boston Scientific, USA) 
was inserted within the Envoy guiding catheter and together with a Transend Platinum 
Tip guidewire (Boston Scientific, USA) navigated under angiographic control to the 
microvasculature (0.5 – 1 mm in lumen diameter) in different parts, of the rabbit. After 
having reached the desired target location, the guidewire was withdrawn from the 
microcatheter and replaced by the Extroducer system protected within a PTFE-190 
Sub-Lite tubing (AgnTho’s, Sweden). The distal penetration tip of the Extroducer was 
pushed out of the protective PTFE-190 tubing and deployed through the arterial wall. 
This was performed both under direct visual control with surgical microscope (Carl 
Zeiss AB, Sweden) and under high magnification fluoroscopic control with subsequent 
digital subtraction series. 
For the acute experiments, the use of a larger guiding catheter allowed for contrast 
injections through the guide catheter. When performing the long term follow up studies, 
a smaller guide catheter was used to minimize trauma to the femoral artery, thereby 
facilitating vascular closure. The downside to that strategy was that it became 
impossible to perform contrast injections through the guide. The Renegade high-flow 
was then a better choice than the Prowler Plus microcatheter since contrast injections 
were possible even with the Extroducer inside the lumen of the micro-catheter. 
Swine endovascular intervention (Un-published data) 
Two swines were included in this preliminary proof of concept study. Several 
interventions were performed in the same swine. Interventions included methylene 
blue- and contrast agent injection of up to 200 µl through the nitinol tube at a flow rate 
of 2 to 5 microliters per second. We obtained XperCT images and reviewed these using 
the XD20 system XperCT Highdose program and soft tissue algorithms (Philips 
Medical Systems, the Netherlands) (Soderman et al. 2008). The XperCT does not give 
optimal images but they are good enough for anatomical charting of the pancreas in 
swine. The obvious advantage with this strategy was that the same equipment could be 
used without moving the swine. 
The femoral artery of the anesthetized swine was exposed surgically and a 5 French 
introducer was inserted (Terumo, USA). Under fluoroscopic control, a 5 French Envoy 
guiding catheter (Cordis Corporation, USA) or a 5 French Cobra guiding catheter was 
navigated to the vasculature of the pancreas. A Renegade micro-catheter (Boston 
Scientific, USA) was inserted within the Envoy guiding catheter and together with a 
Transend Platinum Tip guidewire (Boston Scientific, USA) navigated under 
angiographic control to the microvasculature. After having reached the desired target, 
the guidewire was withdrawn from the microcatheter and replaced with the Extroducer 
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system protected within a PTFE-190 Sub-Lite wall tubing.  Thereafter, the Extroducer 
was deployed through the arterial wall, injections with methylene-blue and contrast 
were performed and the distal penetrating tip of the Extroducer was detached as 
previously described. Thus, in principle, the same methods were used in this setting as 
in the rabbit, but larger introducers and guide catheters made it significantly easier to 
perform the interventions. 
The swine is known to be notoriously hard to perform endovascular interventions in 
due to a strong tendency of vasospasm. Even so rabbit are not usable for pancreas 
access creation since the pancreas of the herbivore is almost nonexistent as opposed to 
the swine with more humanoid organ characteristics. 
Microarray and RT-qPCR (Paper II) 
Cellular mRNA were extracted from cell suspensions with Qiagen RNeasy kit 
(Qiagen, Sweden) according to the manufacturer’s protocol and then analyzed by 
microarray and RT-qPCR. Microarray was used for comparison between human cell 
systems. Thereafter RT-qPCR was used to confirm results from the microarray and to 
include the rNPC in the analysis. 
Tissue handling, Histochemistry and IHC (Paper I through IV) 
Coronal 14 m cryosections of the brain and the other organs were taken using a 
Leica cryostat (CM 3000, Leica Instruments GmbH, Nussloch, Germany). HuN, 
Human Nuclear antigen, a protein found in human cell nuclei but not in rodent nuclei, 
were used as primary antibodies (MAB1281, Chemicon International, Temecula, CA, 
USA) for human cell detection, whereas BrdU antibodies (Dako A/S, Denmark) were 
used for detection of transplanted rodent cells. VCAM-1 or ICAM-1 antibodies were 
used for adhesion molecule detection. 
The brain of each animal was screened for transplanted cells. This was performed by 
analyzing cryosections from the whole brain with immunohistochemistry. Cryosections 
were taken from the rostral to the caudal part of the brain with a 2 mm interval. For 
analyzing the number of cells in the perilesional zone, six different sections with 140 
µm intervals, starting from the lesion center, were analyzed. All transplanted cells in 
the whole ispi- and contralateral hemisphere of each analyzed section were counted. 
For histological analysis of adverse effects by the transplantation such as 
thromboembolic complications, Hematoxylin and Eosin staining were performed 
according to Mayers protocol (Bancroft 1996). 
For evaluating implanted devices we performed histochemical analysis of blocks of 
tissue containing the detached tips.  The appropriate tissue was dissected with 
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fluoroscopic guidance. The tissue blocks were then mounted in plastic and cut by 
specialized ground cutting technique providing the possibility of leaving the metal tip 
in situ. Staining was performed with van Geeson and toulene blue on grind cut blocks 
and then visualized by light-microscopy. 
Statistical analysis (Paper I, II) 
Different groups were analyzed with parametric ANOVA followed by Bonferroni 
corrections for comparison of different groups (Paper I). In paper II, we changed 
statistical method to a non-parametric method using Kruskal-Wallis analysis for 
comparisons between all groups. This was followed by analysis for differences between 
selective i.a. and i.v transplantation by Mann-Whitney U-test for the three cell systems 
with subsequent Bonferroni correction for each comparison (C = 3). One can argue that 
non-parametric analysis should have been used in the first paper as well since small 
samples were used. We have, prior to the writing of this thesis re-analysed the data by 
the non-parametric methods used in paper II and a significance was reached also with 
that method. 
Microarray p-value for signal was generated as an internal control in Beadstudio 
(Illumina Inc., USA) through internal controls randomly placed on the chip. A p-value 
< 0.05 was considered significant in all studies. 
In paper III and IV, no control groups were used since they are all concerned with 
method development. For statistical analysis, the trans-vessel wall technique should be 
compared to other transplantation methods. 
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RESULTS AND DISCUSSION 
In this thesis three different cell transplantation methods are evaluated. The first two 
are the selective intra-arterial method and the intravenous route, these are compared for 
efficacy. The third method is the trans-vessel wall technique by using the Extroducer; 
an endovascular catheter system developed within this thesis for penetrating the vessel 
wall from the inside to out, thereby creating a working channel to extravascular tissue. 
First, we show that, for certain cell types, the selective intra-arterial  method is 
superior to the intravenous one after TBI in the rat. This was measured by the level of 
engraftment of hMSC at one and five days following TBI, without thrombo-embolic 
complications (Paper I). Selective intra-arterial transplantation method for rNPC after 
TBI in the rat is also superior compared to intravenous method. We were, however, not 
able to engraft hNPC, ceteris paribus, thus indicating that diapedesis and engraftment is 
an active process and that different cell systems have different capabilities to engraft 
following intraluminal delivery (Paper II). We show, by indirect methods, that 
CD29CD49dVCAM-1 interactions might be one of the factors with impact on 
engraftment in an intra-luminal transplantation setting (Paper II). Further, we show that 
it is possible to perform minimally invasive parenchymal injections by trans-vessel wall 
technique by the development of the Extroducer (Paper III). The Extroducer is shown 
to have no adverse long term effects on the blood vessels up to 3 months following 
interventions (Paper IV) and it is feasible to use the system as a novel approach for 
transplantation of e.g. insulin producing cells to the pancreas or other cell types to 
organs that are difficult or risky to reach by traditional methods. The trans-vessel wall 
technique thereby adds a new possibility when transplanting cell populations without 
the necessary properties of diapedesis (un-published data). The establishment of a 
working channel to the extravascular tissue, by endovascular method, also open up 
several other possible applications. 
Selective intra-arterial method versus intravenous method (Paper I, II and 
unpublished results) 
We established a model for selective intra-arterial transplantation that we applied to a 
model of TBI in the rat (Feeney et al. 1981). We compared the selective intra-arterial 
method to intra-venous methods for different cell systems in the same TBI setting 
(Paper I and II). Several different variables were tested such as cell concentrations, days 
post injury for transplantation, time for infusion, level of immunosuppressant drugs etc. 
The majority of transplantation experiments were not successful, from the start and 
many different variables were tested before robust engraftments could be reached.Too 
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few cells had a dire impact on the success of transplantation; 200.000 (unpublished 
results) and 500.000 hMSCs did only result in very low levels of engraftment. The 
failure of low cell numbers can obviously be interpreted as an indication that the 
efficacy of the intra arterial method in this setting is quite low although it is still 
superior to intravenous alternatives. 
Results of engraftments levels were obtained through IHC methods by counting 
engrafted cells in sectioned brains (Fig 1). We found that engraftment levels of rNPCs 
were more than five-fold higher than in the control group (p=0.034) and hMSC were 
more than fifteen-fold higher than the in control group in absolute values (p=0.007), 
with a large spread within the intra-arterial groups (Fig 2) (Paper II). Few studies 
compare selective intra-arterial and intravenous methods but recent clinical data 
suggest an advantage for the selective intra-arterial route (Sykova et al. 2006). A 
known problem with all intravenous methods is the fact that the lung acts as a kind of  
Fig 1. In the background is a reconstructed image showing a coronal section of the rat brain 2.5 
mm posterior to bregma stained with GFAP (red) and NeuN (Brown) five days after traumatic brain 
injury. In blow-up a. a low magnification single staining with HuN (human nuclear antigen, MAB 
1281) without any counterstaining, along the peri-lesional zone is shown. Brown dots represent HuN 
positive, transplanted cells (arrow indicates an example of a positive cell). In blow-up b. the black 
area represents the contusion zone and the grey areas represent primary localization of engrafted 
mesenchymal stem cells. In blow-up c. a magnification of the injury area itself is presented. 
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clearance filter during the first passage (Barbash et al. 2003; Fischer et al. 2009). 
Following intravenous cell infusion, the blood transports the cells after venous passage 
to the right ventricle and then through the lung where up to 80% of cells are trapped 
during the first passage (Fischer et al. 2009). Thus as low as 20% of the cells 
transplanted might be ejected for the first total body distribution through the aorta. Of 
all the blood leaving the left ventricle of the heart, only somewhere between 1.8 to 8.5 
Fig 2. Engrafted cells were counted per section and is reported with median (marker), quartiles 
(box) and max – min (whiskers). In A a significant difference between engraftment levels per 
section following selective intra-arterial and intravenous transplantation in the ipsilateral 
hemisphere of the rNPC group. In B a significant difference between engraftment levels per section 
following selective intra-arterial and intravenous transplantation in the ipsilateral hemisphere of 
the hMSC group and finally in C a panel of all engraftment levels per section in the ipsilateral 
hemispheres of all groups. * marks p < 0.05 
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percent of the blood actually reaches the brain of the rat (Pannier et al. 1973) leaving 
only 0.01 to 1.7 percent of the initially transplanted cells to reach the brain in the first 
passage. All cells not distributed to the brain are then again re-transported for another 
passage through the lung, acting as a filter. This phenomenon has been studied e.g. by 
PET for mesenchymal stem cells (Ma et al. 2005). This situation can readily be 
changed by placing a micro-catheter in the arteries supplying the organ of interest. An 
interesting finding in the present study is that our hMSCs predominantly were found in 
the spleen with few transplanted cells in the lung at 24 hours post injection, a bio-
distribution phenomenon, from the lung to the spleen, previously described in rat 
following intravenous hMSC transplantation (Detante et al. 2009). To increase the 
understanding of the role of cell line properties for engraftment, we conducted a study 
with transplantation of different cell lines through either intra-arterial or intravenous 
routes. This analysis showed that there were dramatic differences between the different 
cell lines; hNPCs did not engraft at all after intra-luminal delivery whereas there was a 
significant difference between the hMSCs and the rNPCs using the same 
transplantation method. Noteworthy is the large variability in the engraftment levels of 
the latter two cell lines. One important factor that might contribute to this is that neither 
hMSC nor rNPCs are defined homologous cell lines, succinctly there can be important 
variations within the cell systems transplanted. The remarkable finding that no 
engraftment was obtained following hNPC transplantations is even more noteworthy 
since the hNPCs have previously been robustly transplanted by open surgical technique 
(Wennersten et al. 2004; Akesson et al. 2007). 
Gene expression profiling of cell systems (Paper II) 
After discovering that there were differences in engraftment capability between the 
different cell lines, the opportunity to investigate the bio-molecular basis of said 
differences presented itself. We started with characterizing and confirming earlier 
results (Clausen et al. 2007) that our TBI model leads to up-regulation of VCAM-1 
expression in the endothelium. That result may suggest that the injured CNS 
parenchyma could provide cues for diapedesis and migration of engrafted cells in 
similar ways as immunological cells respond to inflammatory cues (Butcher 1991; 
Springer 1994). As a screening method, we started by performing microarray on the 
human cells. rNPCs were not included in the microarray analysis due to problems with 
cross-species comparisons in the microarray chips used. hMSCs showed a broad 
expression of integrins, commonly expressed by immune  cells, that are important for 
diapedesis through the vessel endothelium and subsequent migration into the 
parenchyma. Specifically, analysis of the heterodimers forming receptors for ICAM-1 
and VCAM-1 were analyzed, based on previous work indicating CD49d expression as 
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important for successful intra-vasal transplantations (Guzman et al. 2008). Thus, 
probably the most interesting finding was the CD49d signal of 68 in hMSC as opposed 
to 0.4 in hNPC (p=0.0047). This was then confirmed with RT-qPCR data from all cell 
lines with average CD49d mRNA levels that were highest in the hMSC (0.98) followed 
by the rNPC (0.0057) and finally a dwindling finding in hNPC (0.0012). CD29 and 
CD49d forms a heterodimer named very late antigen -4 (VLA-4) which was expressed 
in falling order in hMSC, rNSC and hNPC (Fig 3). The difference in mRNA levels 
between rNPC and hNPC is not large but might reflect larger differences in protein 
translation. Further studies at the protein and functional level are required to elucidate 
the importance of CD49d for diapedesis of these cell systems. CD11a mRNA was 
detected in hNPC (0.0029) albeit with low CD18 mRNA (0.00025), suggesting that 
CD11a-CD18-ICAM-1 interaction may be dispensable for engraftment. In contrast, 
hMSC displayed high CD18 mRNA levels (0.43) but no detectable CD11a expression, 
suggesting neglectable ICAM-1 dependent engraftment in the hMSCs. 
 
Fig 3. Bars represent relative levels of integrin CD49d, CD29, CD11a and CD18 mRNA expression 
in rNPC, hNPC and hMSC compared to respective endogenous TBP mRNA levels. Error bars 
represent the distribution between the biological replicates. 
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Finally, both our own findings regarding hNPCs and other previously known cells 
incapable of diapedesis, such as insulin producing cells (Hirshberg et al. 2002), shows 
the apparent need for surgical techniques. In some organs that are hard to reach and/or 
when surgical technique comes with a high risk of adverse events for the patients, the 
need for an alternative strategy becomes apparent. Thus, we also initiated the 
development of the trans-vessel wall approach. 
Computer simulations and Extroducer design (Paper III) 
An endovascularly based system that could penetrate the vessel wall would, in 
instances where the target parenchyma is either hard to reach or carries a significant 
surgical risk, be a method with both the merits of accurate placement and reduction of 
patient risk. Further, it would solve the problem for certain cells to leave the 
bloodstream. 
The development of the Extroducer started with conceptual testing of exit through an 
arterial wall in vivo, more specifically in the tail artery of the rat. This was performed 
with a sharply cut nitinol tube acting as both introducer and Extroducer. This showed 
that no hemorrhage occurred with the device still in place, whereas when the 
penetrating device was retracted, the expected bleeding occurred. Thus the design with 
a hollow detachment zone was initiated where the distal portion of the penetrating 
catheter would be left in place as a plug in the vessel wall. For accurate placement of 
the detachment zone in relation to the inner vascular wall, a depth limiting collar was 
added to the design. After that, several new designs were simulated before returning to 
in vivo testing. 
After detachment of the distal tip, the inner lumen would be open and could 
potentially cause hemorrhage in the target tissue. We performed flow calculations 
through different radii of a distal tip at a pressure of 200 mmHg. Fluid mechanics states 
that the flow rate out of the Extroducer lumen varies as the fourth power of the radius. 
Consequently, the flow rate quickly becomes small as the lumen radius is reduced. In 
practical terms, this gives an auto-sealing effect up to around a 100 µm radius where 
flow of water with a perfect axial entry in the tube is in the range of 100 µl per second 
at physiological blood pressures. When introducing coagulation in the model at low 
and/or turbulent flow it becomes increasingly hard to establish a maximum diameter 
with persisting absence of flow, but it could be up to 150 µm. 
We then performed ex vivo tests on longitudinally cut aortas coupled to a loading cell 
for force measurements with the Extroducer system scaffolded by iron tubing. Initial, 
perpendicular, penetration by the sharp tip was achieved at 11 gram. Full force to 
penetrate the vessel wall with intrusion depth limiting collars was then applied, again 
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augmented by scaffolding iron tubing. We evaluated several different types and sizes of 
intrusion depth limiting collars for optimal performance in relation to catheters and the 
vessel wall. The optimal collar was additionally tested and we found that when using 
the final design, the vessel wall gave away at 45 gram. Therefore with regular plastic 
catheter scaffolding, instead of iron scaffolding, of the Extroducer system, it is 
impossible to overshoot the intrusion depth limiting collar past the vessel wall prior to 
bending the nitinol tube body. 
Integration of the Extroducer system with clinical routine guides, wires and catheters 
was then tested in our simulator environment with an artificial human vascular tree 
connected to rat carcasses. Navigations through the simulator system were all 
successful with full compatibility towards the clinical setting. 
Extroducer in vivo testing - small animals (Paper III) 
After computer simulations and the ex vivo testing, the next part of the study was 
short term testing in rat by creating arterial access from the medial tail artery and 
performing the Extroducer trans-vessel wall technique passage in either the subclavian 
or carotid artery. Two different stages of the procedure was tested; first the trans-vessel 
wall technique passage per se with surgical microscope monitoring of hemorrhage or 
other adverse events, and thereafter the deployment of the distal penetrating tip through 
the vascular wall and retracting the proximal part of the system. No cases of intra-
operative hemorrhage or intra-luminal thrombosis occurred. Thus, the vascular 
penetration procedure was uneventful and the vessel wall completely sealed around the 
Extroducer, thereby preventing leakage of blood. 
The second group with deposited Extroducer tips also showed absolute hemostasis 
during the primary intervention. Fourteen days post intervention, this group showed no 
signs of pain or discomfort. No signs of dissection of the vessels or impairment of 
blood-flow distal to intervention sites were observed and macroscopical analysis of the 
organ supplied by the vessel, showed no infarcts. The flow simulations, indicating 
absence of blood-flow through the interior lumen, was also tested in vivo by 
cannulating the deployed distal tip of the prototypes with a nitinol mandrel. This was 
done to reassure that even when removing possible clotting inside the prototype, it still 
prevented bleeding from inside the vessel to the extravascular space. Furthermore, no 
signs of delayed hemorrhage were detected. 
Extroducer in vivo testing - large animals (Paper III) 
After successful trials in small animals, the Extroducer system was tested in large 
animals. An adaptation towards clinical use was that these prototypes were 
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manufactured from a longer nitinol tube, 1700 mm vis-à-vis 300 mm that was used in 
the rat. We evaluated the prototypes in the rabbit together with standard clinical 
catheters and angiographical equipment. 
The Extroducer prototypes within the microcatheters were visible at high 
magnification fluoroscopy and thereby maneuvered into the subclavian artery (SCA) 
(Fig 4). The rabbit SCA was chosen since it is close to the intended target vessel size of 
0.5 to 3 millimeters, the SCA is fairly easy to access in order to perform simultaneous 
open surgical monitoring and it had been used in the rat. A slight amount of pressure 
was required on the protecting plastic catheter to advance the system through the 
microcatheter to the desired vessel wall, thereafter the Extroducer was gently advanced 
out through the vessel wall to the extra-vascular space. Hemorrhages were neither 
observed by simultaneous direct observation through a surgical microscope, nor by 
high resolution angiographical series (DSA), during and after the intervention (Fig 4). 
Further, no thromboembolic complications or vascular dissections were observed using 
high resolution DSA. No navigational problems were encountered with respect to 
Extroducer prototype integration with clinical catheters. 
Finally, electrolysis detachment of the distal Extroducer distal tip was tested in rabbit. 
We chose electrolysis since it was the easiest way of performing detachment in our 
hands. Our design was  based on the work of the first detachable coils (Guglielmi et al. 
1991). An important difference compared to the detachment zone in coils was, 
however, that we needed a hollow detachment zone which required additional 
development. After navigation to the designated intervention site and after methylene 
blue or contrast agent had been deposited in the extravascular space, a tension of 8V 
was applied and the distal tip was then detached after, on average, five minutes (range 
three to nine minutes). This was also un-eventful without observation of hemorrhage 
from around the body of the distal tip or through the inner lumen. The procedure was 
successfully performed both with simultaneous microscopical monitoring via surgical 
access, and with fluoroscopical/angiographical guidance solely. 
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In a previous work describing a method for penetrating large veins (Thompson et al. 
2003), that system design required a much larger catheter and also lacked a method for 
sealing the vessel wall, thus making penetration through the arteries impossible. This 
severely limits the use of that system to their testing vessel, i.e. the sinus coronarius of 
the heart, whereas the Extroducer is applicable in both arteries and veins of any sizes 
down to approximately 0.5 mm in diameter. Another system, in which vessel 
perforations are performed, is the trans-jugular intrahepatic portacaval stent shunt 
(TIPS) technique (Richter et al. 1990). That system also does not have the requirement 
of sealing the vessel wall when finishing the procedure, since a patent blood flow 
Fig 4. For full control over the procedure in the large animal trials, both a surgical microscope and 
high resolution angiographical series was used. In a. digital subtraction angiogram showing a 
detached Extroducer tip without hemorrhage, dissection or thromboembolic complications. In b. 
photograph showing the microsurgical view of the detached Extroducer tip. In c. x-ray image showing 
the detached Extroducer tip with guide catheter. In d. photograph from post-operative dissection 
showing the detached Extroducer tip with methylene blue injected in the surrounding tissue. In e. 
digital subtraction angiogram showing an extra vascular injection of 25 µl contrast agent through the 
Extroducer system. 
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through the stent is the preferred result. On the contrary, thrombosis of the stent might 
be considered the main problem (Merli et al. 1998) which requires rigorous follow-up. 
Thus, the Extroducer system is unique in the ways that it permits safe exit of both 
arteries and veins and that it is usable in vessels with large dimensions as well as in the 
microvasculature with inner lumen diameters down to approximately 0.5 mm. 
Extroducer testing with long time follow up (Paper IV) 
In the long term follow up, the end points five days, one month and three months after 
the deployment of the device was selected. No stenosis or late hemorrhagic 
complications were noted in any animals. No alterations in behavior or other measures 
of discomfort were noted either. 
We started with a total number of 25 primary trans-vessel wall interventions in 17 
animals. Working channels were established in 100% of the cases without acute 
hemorrhagic or thrombo-embolic events, verified by DSA. Six of the interventions 
were aborted due to distal tip detachment failure with our hand-made relatively 
primitive electrolysis detachment method (leading to euthanasia of 3 animals and 3 that 
we were able to salvage to stay in the study). Two animals were euthanized by order of 
the veterinarian during the follow-up period, one because of a non-related pulmonary 
infection (but included and analyzed by histology) and the other since it fulfilled the 
behavioral abortion point criteria after 24 hours (excluded from the study). That animal 
was then autopsied and was found to have an embolic occlusion of the internal carotid 
artery without association to the Extroducer placement, but rather associated with the 
vascular navigation. The final distribution of followed up animals were as follows; two 
at the five days end point with only histological analysis of one, five at the 30 days end 
point and six at the 80 days end point with histological analysis of one (with pulmonary 
infection) resulting in a total number of 19 detached Extroducer tips. 
In the follow up DSA we also found that four of 19 (21 %) of the detached tips were 
no longer placed through the vessel wall but had instead been “pushed” or “migrated” 
through the endothelium to the extravascular space immediately adjacent to the 
penetration site. No vascular stenosis or other adverse reactions were observed around 
those tips. Also for the rest of the tips, that were located through the vessel wall, no 
adverse reactions were detected. During initial testing, five prototypes, detached 
precisely in the rotator plan of the humero-scapular joints in the SCA, were dislodged 
into the lumen of the vessel with the depth limiting collar pointing distally in the flow 
of blood. This phenomenon occurred due to the fact that the anterior extremities of the 
rabbit were flexed in a certain position during anesthesia and that the five Extroducer 
tips were detached exactly in the plane of movement of the joint. Thus, the detached tip  
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was pushed into the vessel immediately when changing the position of the extremity 
during wake up. For all other prototypes, detached within other segments (millimeter 
more proximal or distal) of the SCA and in all other vascular segments tested in the 
body, this phenomenon was not observed.An important endpoint was biocompatibility 
of the detached tips. The nitinol alloy used was selected for its many advantageous 
properties. Nitinol is a nickel/titanium alloy with both memory and super elastic 
properties (Adler et al. 1990). These special properties are the foundation for the use of 
nitinol in stent fabrication in clinical practice. Thus, the excellent biocompatibility of 
nitinol (Castleman et al. 1976) has been extensively studied, especially with respect to 
vessel wall interactions in the use of stents (Stoeckel et al. 2004). However, the 
compatibility of nitinol when placed through arterial walls have, to our knowledge, not 
been studied. The parylene, used as coating in our device, is also FDA approved and 
CE marked when used in pacemaker electrodes. To evaluate interaction between the 
deposited tips and the endothelium, we performed histological analysis with the 
Fig 5. In a. the initial follow up angiogram directly following detachment in the Superior 
Mesenteric Artery (SMA) is shown with a square marking the blow-up in b. Arrows indicate the 
detached distal tip. In c. an SMA angiogram, performed 80 days after the intervention in the same 
animal, is shown with a square indicating the blow-up in d. Arrows indicate the detached distal tip. 
In e. a microphotograph of a histological van Geeson and toulene blue staining prepared by grind-
cutting with the detached tip in situ, is shown. Scale bar = 100 µm. The blow-up in f shows the 
parylene coating surrounding the detached tip which is marked by an arrow. Note that no fibrous 
response or inflammation is observable. Scale bar = 4 µm. 
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prototypes in situ by a specialized grind-cutting technique and then consulted an 
external, independent, evaluator with expertise in the field of titanium implants. This 
evaluation showed full biocompatibility with a very small fibrotic capsule (< 1 µm) 
formed around the detached distal tips (fig 5). No ongoing inflammation was 
observable around any of the distal tips. Around one (of the total number 14 left in 
place) of the day five animal implants, three macrophages were indentified in the area 
of the detached distal tip. Apart from those three macrophages, no other signs of 
inflammation were observed. The endothelia showed no signs of alterations adjacent to 
the deposited tips. In conclusion, the biocompatibility of the distal tips were all 
comparable to titanium implants. The interactions of nitinol with the interior of the 
vascular wall and the extra vascular space has not been as extensively studied since 
stents most often are positioned inside the vascular lumen with direct contact only with 
the bloodstream and the endothelium. Therefore, the present histological analysis in 
this new application and new position of nitinol, adds important knowledge about 
biocompatibility for possible future applications. 
The prototypes excluded due to failed detachment were analyzed by sweep electron 
microscopy (SEM), since monitoring of electric current gave limited prognostic 
information about the failure to detach. We found that, in failed detachments, large 
amounts of chloride were observed by surface spectroscopy (6-10 wt %) indicating 
titanium chloride ion formations in a passive layer, thus providing current transmission 
without electrolysis. Titanium chloride molecules can provide a surface area that lets 
electron pass through but without formation of soluble titanium or nickel ions. This 
problem is probably due to the simple technique used for creating the insulation defect 
in our hands. However, numerous available solutions for detachment are available on 
the market that can easily be integrated with the trans-vessel wall technique in an 
industrialized manufacturing process. 
A model for multiple interventions in rabbit was also established. Application of 
tissue glue directly after retracting the femoral introducer, made it possible to, at all 
time-points, to establish new endovascular access in the same femoral artery. This has 
implications for endovascular research with the rabbit for numerous research projects. 
Extroducer proof of concept study with pancreas access (Un-published data) 
After initial testing of the concept and long term follow, up a preliminary feasibility 
study was designed to address a known clinical problem; the inherit risk of adverse 
event (Villiger et al. 2005), low efficacy (Korsgren et al. 2008) and sub-optimal micro-
environment in the liver (Merani et al. 2008) of the portal vein approach to 
transplantation of insulin producing cells. A swine model was chosen and we started by 
acquiring anatomical information through XperCT, a method of obtaining CT images 
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with the C-arm of the angiographical equipment (Fig 5) (Soderman et al. 2008). After 
initial planning, we performed DSA series as road maps (Smart Mask™) to navigate 
the micro catheter to the chosen point of intervention. When reaching tip to tip with the 
micro catheter, the Extroducer was gently pushed out through the vessel wall thereby 
creating a working channel between the proximal end of the catheter and the pancreas 
parenchyma, usable for e.g. transplantation of insulin producing cells (fig 6). No 
haemorrhage or embolic complications were observed when creating access to the 
parenchyma. Vasospasm was observed and could be reversed with intra-arterial 
infusion of the calcium-channel blocker nimodipin. 
 
Fig 6. Following the interventions, cadaver dissections were performed. In A, an overview from the 
dissection shows small fragment of blue colour on the outside of the pancreas followed by higher 
magnification of the pancreas itself in B and finally in C, an operating microscope view to illustrate 
the placement of the detached distal tip in the vessel. 
 
On Endovascular methods for cell transplantation 
 
34 
We performed injections of a blue coloured dye (methylene-blue) to mark 
parenchymal access which was confirmed by subsequent autopsy. Dissections of the 
swine showed the deposited methylene blue located in the middle of the pancreatic 
parenchyma (fig 6). Further the detached distal parts of the Extroducer were observed 
in the vessel walls within the pancreas, surrounded by methylene blue staining (fig 6). 
In addition, during the intervention, a contrast agent was injected through the 
Extroducer system to demonstrate that the deposited contrast was not washed out with 
the blood stream thereby confirming extra vascular access to the pancreas (fig 6). 
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GENERAL DISCUSSION 
The rationale for the studies comprising this thesis is that when translating cell based 
regenerative medicine to patients, the actual route of transplantation will be very 
important. For operative techniques there is a problem with scalability and for 
intravenous techniques there is a problem with efficacy. We show that by selective 
intra-arterial methods it is possible to increase the level of cerebral engraftment with 
certain cell types with six to fifteen fold yields. Further, not all cells are optimal for 
intra-luminal transplantation. It is, for example, known that insulin producing cells lack 
the capability to perform diapedesis (Hirshberg et al. 2002) and we show that hNPC, a 
cell system previously transplanted by open surgical means (Wennersten et al. 2004) 
also lacks the capability to perform diapedesis. For these cell systems, and other 
applications, we have developed the Extroducer as a tool to establish a direct, minimal 
invasive working channel with parenchymal access in organs that are difficult or risky 
to reach with traditional techniques. 
The first passage of cells delivered through selective intra-arterial approaches, 
compared to systemic intravenous delivery, results in a higher local concentration, 
shorter blood stream exposure and less mechanical stress factors before cells reach the 
target site. These factors could be of importance for successful engraftment. Supporting 
that hypothesis are the present results showing significantly higher total cerebral uptake 
of cells after intra-arterial compared to intra-venous administration. The next 
supporting fact is the higher uptake of cells in the ipsilateral hemisphere after intra-
arterial administration and by the absence of difference between the hemispheres after 
intravenous transplantation. Future studies are needed for elucidating molecules 
responsible for diapedesis, e.g by direct methods such as knock ins, of for example 
CD49d, in non-functioning cell systems and knock down or blocking in other cell 
systems. 
The absence of adverse effects in transplanted animals suggests that in the short term, 
the selective intra-arterial transplantation method is safe for delivering even high 
concentrations of cells. It has been reported ischemic events following intra-arterial 
approaches to the heart in dogs (Vulliet et al. 2004) thus indicating the need for 
thorough studies prior to translation into clinical practice. However, in clinical studies 
on intracoronary infusions (Stamm et al. 2003) and in spinal cord artery infusions 
(Sykova et al. 2006) no embolic events have been recorded. Connected to the need for 
safety studies, it could be argued that the higher engraftment rates in our intra-arterial 
groups would be a consequence of microembolization of cells. In that scenario we 
would, however, have detected ischemic histological changes and localization of the 
transplanted cells within arterioles and capillaries, which we did not. 
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For all intra-luminal approaches, this thesis shows that a thorough investigation must 
be performed to clarify if the cells actually can perform diapedesis prior to choosing 
transplantation strategy. hNPCs has previously been shown to have an impact on 
neurological outcome when transplanted with open surgical techniques, but in their 
present form they seem unsuitable for intra-luminal transplantation. Therefore, based 
on the findings in this thesis, considerations should be made that CD29CD49dVCAM-1 
interaction is one of the best studied crosstalk mechanisms on how immunological cells 
leave the bloodstream to perform homing to disease ridden tissue where inflammation 
occurs (Elices et al. 1990). This line of reasoning is supported by other studies 
implicating VCAM-1 interaction in both ischemic stroke and muscle dystrophy pre-
clinical studies (Gavina et al. 2006; Guzman et al. 2008). An interesting comparison 
can be made regarding diapedesis in cell systems aimed for transplantation compared to 
immunological cells. In such an exercise it could be considered blatantly ignorant to 
immediately dismiss the fylogenetically conserved mechanism of the immunological 
system and suggest a hitherto unknown method of diapedesis for these cells. Applying 
Occam’s razor to the hypothesis of diapedesis for cell transplantation, two conclusions 
can potentially be made; i) the process of diapedesis is most probably an active process 
for cell systems transplanted, since there are no known inactive ways of diapedesis and 
ii) the most likely system for diapedesis crosstalk should be found within the same 
systems that are used by the immunological system, meaning that proteins are highly 
likely to come from the Ig-super family such as VCAM-1. The other, more complex, 
explanation would be that a hitherto unknown system for diapedesis exists. That it also 
unlikely since mutations in such a system would lead to genetical diseases that should 
be known, but without reasonable explanations. A research program dedicated on 
endovascular transplantation of different cell systems in different diseases should 
include a variety of diseases and cell systems to increase the understanding of both cell-
endothelium interactions and the effects on target niches. 
When designing both pre-clinical and clinical cell transplantation studies, 
consideration should be taken to how the cells are hypothesized to reach their 
designated targets. The first option might be open surgical techniques for small niche 
locations in a target parenchyma. Downsides to open surgical/percutaneous techniques 
are e.g. impracticalities of accruing the desired extent of target tissue volume, 
especially if the volume is relatively large, such as following a major CNS insult. 
Further, the patient risk for adverse events might be unacceptable in relation to a 
potential benefit, in particular for “difficult to reach” organs such as the CNS, the 
pancreas and/or the heart. If the disadvantages of open surgical/percutaneous 
techniques are unacceptable, intra-luminal options could be explored. For intra-luminal 
approaches, the concept of how transplanted cells are presumed to leave the blood 
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stream becomes an issue with several potential solutions. For a cell system without the 
necessary features for diapedesis, one could use knock-in methods to provide the 
necessary adhesion molecule set up, otherwise intra-parenchymal injections must be 
considered. For knock-in methods, an intra-arterial approach would probably still have 
benefits in efficacy over intravenous methods through the first passage effect and by 
avoiding pulmonary trapping. As previously discussed an interesting purely academical 
calculation when performing intravenous cell transplantations could result in such a 
low cell dose to the brain as 0.01 to 1.7% after intravenous injection. Assuming 80% of 
cells are trapped, in the first passage of the lung (Barbash et al. 2003; Fischer et al. 
2009). This can readily be changed by placing a micro-catheter in vessels supplying the 
target parenchyma with blood thereby providing a chance for all cells to perfuse the 
target parenchyma. 
For more discrete functioning cells, an intra-parenchymal injection might be even 
more attractive for reasons such as shielding the cells from the exposure to the 
bloodstream and accurate anatomical placement. In difficult to reach organs, minimally 
invasive direct parenchymal transplantation could be performed by the trans-vessel wall 
technique described within this thesis. That technique might, however, not be suitable 
for treating a large ischemic lesion in humans. On the contrary, in discrete lesions 
where only a niche cell needs to be replaced, such as in type I diabetes, where the cells 
do not possess properties for diapedesis, the Extroducer could potentially really show 
its worth. The next natural step is transplantation of insulin producing cells to swine 
before planning for clinical trials.  
The Extroducer is not limited to cell transplantation. Its main design is to provide a 
working channel by endovascular technique to the parenchyma in various, otherwise, 
inaccessible organs. Through that working channel, other procedures such as local 
chemotherapy-, irradiation-, growth factor administration, tissue sampling, 
electrophysiological diagnostics and thermo-therapy becomes possible. Further, 
combined with optical spectroscopic analysis, it might even be possible to perform 
infra-light histological analysis of tissue via the Extroducer. 
General conclusions 
In the articles compiling this thesis we first show that selective intra-arterial 
administration is a safe way, with a short follow up time, to increase engraftment levels 
compared to intravenous delivery. However, not all cell systems are optimal for intra-
luminal transplantation. These factors might be dependent on integrin expression and 
endothelium interactions. For cells that lack the capacity to perform diapedesis, and 
especially for more specific niche cell systems in organ systems that are difficult to 
reach, we have also developed a system for trans-vessel wall parenchymal access. The 
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Extroducer system has been evaluated both for long term effects and feasibility for 
pancreas access. Ergo, endovascular intervention should provide a number of methods 
for efficient and safe cell transplantation in current and future clinical practice. The 
transplantation method must be decided on a disease to disease, cell to cell and patient 
to patient manner. 
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CONCLUSIONS 
i. It is possible to transplant cells to the CNS by selective intra-arterial 
technique and it results in significantly increased engraftment compared 
to intravenous cell administration. 
 
ii. All cell systems are not optimal for intra-luminal approaches. Possibly 
this is dependent on integrin expression of the cell systems transplanted 
and the cross-talk with the endothelium in the CNS parenchyma. 
 
iii. CD29CD49d and VCAM-1 interactions appear pivotal for creating CNS 
parenchymal engraftment after intra-luminal cell delivery. 
 
iv. The Extroducer system renders parenchymal cell transplantation and 
substance administration possible by trans-vessel wall technique, using 
standard clinical catheters and angiographical equipment, without 
hemorrhagic- or thrombo-embolic complications. 
 
v. The distal tips, provided for securing the vessel wall defect, cause no 
adverse events with up to three months follow-up. 
 
vi. It is conceptually possible to use the Extroducer system for 
transplantation of insulin-producing cells to the pancreas of large animals 
with full clinical integration. 
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